KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.

Mottl, Amy K; Alicic, Radica; Argyropoulos, Christos; Brosius, Frank C; Mauer, Michael; Molitch, Mark; Nelson, Robert G; Perreault, Leigh; Nicholas, Susanne B

Mottl, Amy K; Alicic, Radica; Argyropoulos, Christos; Brosius, Frank C; Mauer, Michael; Molitch, Mark; Nelson, Robert G; Perreault, Leigh; Nicholas, Susanne B.

Afiliação

Mottl AK; University of North Carolina Kidney Center, University of North Carolina Kidney Center School of Medicine, Chapel Hill, North Carolina. Electronic address: amy_mottl@med.unc.edu.
Alicic R; Providence Medical Research Center, Providence Health Care, Spokane, Washington; Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Argyropoulos C; Division of Nephrology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
Brosius FC; Department of Medicine, University of Arizona, Tucson, Arizona; Departments of Internal Medicine and Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.
Mauer M; Departments of Pediatrics and Medicine, University of Minnesota, Minneapolis, Minnesota.
Molitch M; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Nelson RG; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona.
Perreault L; Division of Endocrinology, Metabolism and Diabetes Affiliate, Center for Global Health, University of Colorado Anschutz Medical Campus and Colorado School of Public Health, Aurora, Colorado.
Nicholas SB; Divisions of Nephrology and Endocrinology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

Am J Kidney Dis ; 79(4): 457-479, 2022 04.

Article em En | MEDLINE | ID: mdl-35144840

Assuntos

Diabetes Mellitus; Nefrologia; Insuficiência Renal Crônica; Inibidores do Transportador 2 de Sódio-Glicose; Humanos; Hipoglicemiantes/uso terapêutico; Rim; Insuficiência Renal Crônica/complicações; Insuficiência Renal Crônica/terapia; Inibidores do Transportador 2 de Sódio-Glicose/uso terapêutico

Palavras-chave

Diabetes; SGLT2 inhibitors; blood pressure control; chronic kidney disease (CKD); commentary; evidence-based recommendation; glucagon-like peptide 1 receptor agonists; glycemic targets; guideline implementation; guidelines; metformin; nephrology best practices; physical activity; protein intake; smoking; sodium intake

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções APS: Guias_protocolos_manuais_internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose / Nefrologia Limite: Humans Idioma: En Ano de publicação: 2022

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google